Journal Home > Volume 9 , Issue 1
Brain Science Advances 2023, 9(1): 43-52 https://doi.org/10.26599/BSA.2023.9050004
Review Article | Open Access | Issue | Published: 27 February 2023

The regulation of host cytoskeleton during SARS-CoV-2 infection in the nervous system

Show Author's Information Qian Zhang1,  Yaming Jiu1,2( )
Unit of Cell Biology and Imaging Study of Pathogen Host Interaction, The Center for Microbes, Development and Health, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China
University of Chinese Academy of Sciences, Beijing 100049, China
Keywords:
cytoskeleton, nervous system, SARS-CoV-2 virus infection, actin filaments, microtubule, intermediate filaments
Cite this article:
Zhang Q, Jiu Y. The regulation of host cytoskeleton during SARS-CoV-2 infection in the nervous system. Brain Science Advances, 2023, 9(1): 43-52. https://doi.org/10.26599/BSA.2023.9050004
Download citation
EndNote(RIS)
BibTeX

994

Views

133

Downloads

Citations

2

Crossref

N/A

WoS

N/A

Scopus

N/A

CSCD

Abstract Full text About this article

The global economy and public health are currently under enormous pressure since the outbreak of COVID-19. Apart from respiratory discomfort, a subpopulation of COVID-19 patients exhibits neurological symptoms such as headache, myalgia, and loss of smell. Some have even shown encephalitis and necrotizing hemorrhagic encephalopathy. The cytoskeleton of nerve cells changes drastically in these pathologies, indicating that the cytoskeleton and its related proteins are closely related to the pathogenesis of nervous system diseases. In this review, we present the up-to-date association between host cytoskeleton and coronavirus infection in the context of the nervous system. We systematically summarize cytoskeleton-related pathogen-host interactions in both the peripheral and central nervous systems, hoping to contribute to the development of clinical treatment in COVID-19 patients.


menu
Abstract
Full text
Outline
About this article

The regulation of host cytoskeleton during SARS-CoV-2 infection in the nervous system

Show Author's information Qian Zhang1, Yaming Jiu1,2( )
Unit of Cell Biology and Imaging Study of Pathogen Host Interaction, The Center for Microbes, Development and Health, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China
University of Chinese Academy of Sciences, Beijing 100049, China

Abstract

The global economy and public health are currently under enormous pressure since the outbreak of COVID-19. Apart from respiratory discomfort, a subpopulation of COVID-19 patients exhibits neurological symptoms such as headache, myalgia, and loss of smell. Some have even shown encephalitis and necrotizing hemorrhagic encephalopathy. The cytoskeleton of nerve cells changes drastically in these pathologies, indicating that the cytoskeleton and its related proteins are closely related to the pathogenesis of nervous system diseases. In this review, we present the up-to-date association between host cytoskeleton and coronavirus infection in the context of the nervous system. We systematically summarize cytoskeleton-related pathogen-host interactions in both the peripheral and central nervous systems, hoping to contribute to the development of clinical treatment in COVID-19 patients.

Keywords: cytoskeleton, nervous system, SARS-CoV-2 virus infection, actin filaments, microtubule, intermediate filaments

References(55)

[1]
Shi XM, Fan CY, Jiu YM. Unidirectional regulation of vimentin intermediate filaments to caveolin-1. Int J Mol Sci 2020, 21(20): 7436.
DOI Google Scholar
[2]
Wang JY, Zhang W, Roehrl MW, et al. An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19. J Autoimmun 2021, 120: 102644.
DOI Google Scholar
[3]
Helfand BT, Mendez MG, Murthy SNP, et al. Vimentin organization modulates the formation of lamellipodia. MBoC 2011, 22(8): 1274–1289.
DOI Google Scholar
[4]
Cheever TR, Ervasti JM. Actin isoforms in neuronal development and function. Int Rev Cell Mol Biol 2013, 301: 157–213.
DOI Google Scholar
[5]
Zandi F, Khalaj V, Goshadrou F, et al. Rabies virus matrix protein targets host actin cytoskeleton: a protein-protein interaction analysis. Pathog Dis 2021, 79(1): ftaa075.
DOI Google Scholar
[6]
Jhan MK, Tsai TT, Chen CL, et al. Dengue virus infection increases microglial cell migration. Sci Rep 2017, 7(1): 91.
DOI Google Scholar
[7]
Zhao SS, Gao JK, Zhu LQ, et al. Transmissible gastroenteritis virus and porcine epidemic diarrhoea virus infection induces dramatic changes in the tight junctions and microfilaments of polarized IPEC-J2 cells. Virus Res 2014, 192: 34–45.
DOI Google Scholar
[8]
Janke C, Kneussel M. Tubulin post-translational modifications: encoding functions on the neuronal microtubule cytoskeleton. Trends Neurosci 2010, 33(8): 362–372.
DOI Google Scholar
[9]
Xiao QP, Hu XH, Wei ZY, et al. Cytoskeleton molecular motors: structures and their functions in neuron. Int J Biol Sci 2016, 12(9): 1083–1092.
DOI Google Scholar
[10]
Trushina NI, Mulkidjanian AY, Brandt R. The microtubule skeleton and the evolution of neuronal complexity in vertebrates. Biol Chem 2019, 400(9): 1163–1179.
DOI Google Scholar
[11]
Hahn I, Voelzmann A, Liew YT, et al. The model of local axon homeostasis - explaining the role and regulation of microtubule bundles in axon maintenance and pathology. Neural Dev 2019, 14(1): 11.
DOI Google Scholar
[12]
Baas PW, Rao AN, Matamoros AJ, et al. Stability properties of neuronal microtubules. Cytoskeleton (Hoboken) 2016, 73(9): 442–460.
DOI Google Scholar
[13]
Sodeik B, Ebersold MW, Helenius A. Microtubule-mediated transport of incoming Herpes simplex virus 1 capsids to the nucleus. J Cell Biol 1997, 136(5): 1007–1021.
DOI Google Scholar
[14]
Suomalainen M, Nakano MY, Keller S, et al. Microtubule-dependent plus- and minus end-directed motilities are competing processes for nuclear targeting of adenovirus. J Cell Biol 1999, 144(4): 657–672.
DOI Google Scholar
[15]
Suikkanen S, Aaltonen T, Nevalainen M, et al. Exploitation of microtubule cytoskeleton and dynein during parvoviral traffic toward the nucleus. J Virol 2003, 77(19): 10270–10279.
DOI Google Scholar
[16]
Wang IH, Burckhardt CJ, Yakimovich A, et al. Imaging, tracking and computational analyses of virus entry and egress with the cytoskeleton. Viruses 2018, 10(4): 166.
DOI Google Scholar
[17]
Yuan AD, Rao MV, Veeranna, et al. Neurofilaments and neurofilament proteins in health and disease. Cold Spring Harb Perspect Biol 2017, 9(4): a018309.
DOI Google Scholar
[18]
Yang LF, Tang L, Dai F, et al. Raf-1/CK2 and RhoA/ROCK signaling promote TNF-α-mediated endothelial apoptosis via regulating vimentin cytoskeleton. Toxicology 2017, 389: 74–84.
DOI Google Scholar
[19]
Ehrenreiter K, Piazzolla D, Velamoor V, et al. Raf-1 regulates Rho signaling and cell migration. J Cell Biol 2005, 168(6): 955–964.
DOI Google Scholar
[20]
Larsson C. Protein kinase C and the regulation of the actin cytoskeleton. Cell Signal 2006, 18(3): 276–284.
DOI Google Scholar
[21]
Galigniana NM, Charó NL, Uranga R, et al. Oxidative stress induces transcription of telomeric repeat-containing RNA (TERRA) by engaging PKA signaling and cytoskeleton dynamics. Biochim Biophys Acta BBA Mol Cell Res 2020, 1867(4): 118643.
DOI Google Scholar
[22]
Benoit B, Baillet A, Poüs C. Cytoskeleton and associated proteins: pleiotropic JNK substrates and regulators. Int J Mol Sci 2021, 22(16): 8375.
DOI Google Scholar
[23]
Choong G, Liu Y, Templeton DM. Cadmium affects focal adhesion kinase (FAK) in mesangial cells: involvement of CaMK-II and the actin cytoskeleton. J Cell Biochem 2013, 114(8): 1832–1842.
DOI Google Scholar
[24]
Beziau A, Brand D, Piver E. The role of phosphatidylinositol phosphate kinases during viral infection. Viruses 2020, 12(10): 1124.
DOI Google Scholar
[25]
Dunn CW, Hejnol A, Matus DQ, et al. Broad phylogenomic sampling improves resolution of the animal tree of life. Nature 2008, 452(7188): 745–749.
DOI Google Scholar
[26]
Netland J, Meyerholz DK, Moore S, et al. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 2008, 82(15): 7264–7275.
DOI Google Scholar
[27]
Seixas AI, Azevedo MM, de Faria JP, et al. Evolvability of the actin cytoskeleton in oligodendrocytes during central nervous system development and aging. Cell Mol Life Sci 2019, 76(1): 1–11.
DOI Google Scholar
[28]
Wilson R, Brophy PJ. Role for the oligodendrocyte cytoskeleton in myelination. J Neurosci Res 1989, 22(4): 439–448.
DOI Google Scholar
[29]
Kachar B, Behar T, Dubois-Dalcq M. Cell shape and motility of oligodendrocytes cultured without neurons. Cell Tissue Res 1986, 244(1): 27–38.
DOI Google Scholar
[30]
Meinhardt J, Radke J, Dittmayer C, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci 2021, 24(2): 168–175.
DOI Google Scholar
[31]
Kirtipal N, Bharadwaj S, Kang SG. From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses. Infect Genet Evol 2020, 85: 104502.
DOI Google Scholar
[32]
Jackson CB, Farzan M, Chen B, et al. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol 2022, 23(1): 3–20.
DOI Google Scholar
[33]
Wang FZ, Kream RM, Stefano GB. Long-term respiratory and neurological sequelae of COVID-19. Med Sci Monit 2020, 26: e928996.
DOI Google Scholar
[34]
Jha NK, Ojha S, Jha SK, et al. Evidence of coronavirus (CoV) pathogenesis and emerging pathogen SARS-CoV-2 in the nervous system: a review on neurological impairments and manifestations. J Mol Neurosci 2021, 71(11): 2192–2209.
DOI Google Scholar
[35]
Andalib S, Biller J, Di Napoli M, et al. Peripheral nervous system manifestations associated with COVID-19. Curr Neurol Neurosci Rep 2021, 21(3): 9.
DOI Google Scholar
[36]
Karki R, Sharma BR, Tuladhar S, et al. Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell 2021, 184(1): 149–168.e17.
DOI Google Scholar
[37]
Keaney J, Campbell M. The dynamic blood-brain barrier. FEBS J 2015, 282(21): 4067–4079.
DOI Google Scholar
[38]
Cheng JP, Korte N, Nortley R, et al. Targeting pericytes for therapeutic approaches to neurological disorders. Acta Neuropathol 2018, 136(4): 507–523.
DOI Google Scholar
[39]
Bilinska K, Jakubowska P, Von Bartheld CS, et al. Expression of the SARS-CoV-2 entry proteins, ACE2 and TMPRSS2, in cells of the olfactory epithelium: identification of cell types and trends with age. ACS Chem Neurosci 2020, 11(11): 1555–1562.
DOI Google Scholar
[40]
Zubair AS, McAlpine LS, Gardin T, et al. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol 2020, 77(8): 1018–1027.
DOI Google Scholar
[41]
de F Ferreira ACA, Romão TT, Macedo YS, et al. COVID-19 and Herpes zoster co-infection presenting with trigeminal neuropathy. Eur J Neurol 2020, 27(9): 1748–1750.
DOI Google Scholar
[42]
DeOre BJ, Tran KA, Andrews AM, et al. SARS-CoV-2 spike protein disrupts blood-brain barrier integrity via RhoA activation. J Neuroimmune Pharmacol 2021, 16(4): 722–728.
DOI Google Scholar
[43]
Thakur KT, Miller EH, Glendinning MD, et al. COVID-19 neuropathology at Columbia university Irving medical center/new york Presbyterian hospital. Brain 2021, 144(9): 2696–2708.
DOI Google Scholar
[44]
Mao L, Jin HJ, Wang MD, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020, 77(6): 683–690.
DOI Google Scholar
[45]
Klok FA, Kruip MA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020, 191: 145–147.
DOI Google Scholar
[46]
Matschke J, Lütgehetmann M, Hagel C, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 2020, 19(11): 919–929.
DOI Google Scholar
[47]
Schurink B, Roos E, Radonic T, et al. Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study. Lancet Microbe 2020, 1(7): e290–e299.
DOI Google Scholar
[48]
Moss KR, Bopp TS, Johnson AE, et al. New evidence for secondary axonal degeneration in demyelinating neuropathies. Neurosci Lett 2021, 744: 135595.
DOI Google Scholar
[49]
Rahman MA, Islam K, Rahman S, et al. Neurobiochemical cross-talk between COVID-19 and alzheimer’s disease. Mol Neurobiol 2021, 58(3): 1017–1023.
DOI Google Scholar
[50]
Cancino GI, Yiu AP, Fatt MP, et al. p63 Regulates adult neural precursor and newly born neuron survival to control hippocampal-dependent Behavior. J Neurosci 2013, 33(31): 12569–12585.
DOI Google Scholar
[51]
Abbott NJ, Patabendige AAK, Dolman DEM, et al. Structure and function of the blood-brain barrier. Neurobiol Dis 2010, 37(1): 13–25.
DOI Google Scholar
[52]
Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005, 57(2): 173–185.
DOI Google Scholar
[53]
Buzhdygan TP, DeOre BJ, Baldwin-Leclair A, et al. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol Dis 2020, 146: 105131.
DOI Google Scholar
[54]
Kimura K, Eguchi S. Angiotensin II type-1 receptor regulates RhoA and Rho-kinase/ROCK activation via multiple mechanisms. Focus on Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells. Am J Physiol Cell Physiol 2009, 297(5): C1059–C1061.
DOI Google Scholar
[55]
Bradke F, Roll-Mecak A. Editorial overview: Microtubules in nervous system development. Develop Neurobiol 2021, 81(3): 229–230.
DOI Google Scholar
Publication history
Copyright
Rights and permissions

Publication history

Received: 17 November 2022
Revised: 30 November 2022
Accepted: 05 December 2022
Published: 27 February 2023
Issue date: March 2023

Copyright

© The authors 2023.

Rights and permissions

This article is published with open access at journals.sagepub.com/home/BSA

Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

Return